Current Rheumatology Reports

, Volume 1, Issue 2, pp 139–148 | Cite as

Animal models of rheumatoid arthritis and related inflammation

  • Bina Joe
  • Marie M. Griffiths
  • Elaine F. Remmers
  • Ronald L. Wilder


The major, extensively studied, experimentally-induced rat and mouse models of arthritis with features resembling rheumatoid arthritis are reviewed here. Etiopathogenetic studies that were recently published are emphasized. In summary, multiple triggering stimuli can induce disease in genetically-prone strains of inbred rats and mice. Multiple genetic loci, including both MHC and non-MHC, regulate disease expression in these animals. By comparison with other models of autoimmune disease, clustering of regulatory loci within and among species is increasingly becoming evident. At the cellular level, both innate and acquired immune systems are involved in the disease manifestations. At the molecular level, unbalanced chronic production of tumor necrosis factor-a (TNF-a), interleukin (IL)-1, IL-6 and IL-12, as opposed to IL-4 and IL-10, is correlated with arthritis disease susceptibility and severity.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Wilder RL, Remmers EF, Kawahito Y, et al.: Genetic factors regulating experimental arthritis in mice and rats. In Current Directions in Autoimmunity, vol 1. Edited by Theophilopoulos AN. Basel Karger, 1999:121–165. This is a comprehensive chapter dealing with the genetics of animal models of arthritis with an exhaustive list of cited references pertain-ing to rat and mouse models of arthritis. Publications in the field until early 1998 have been reviewed. Informative tables summarize susceptibility to and severity of arthritis in rat and mouse models and the genetic regulatory loci controlling arthritis in rats.Google Scholar
  2. 2.
    Crofford LJ, Wilder RL: Arthritis and autoimmunity in animals. In Arthritis and Allied Conditions, vol 13. Edited by Koopman W. Baltimore: Williams and Wilkins; 1997:565–583.Google Scholar
  3. 3.
    Lorentzen JC: Identification of arthritogenic adjuvants of self and foreign origin. Scand J Immunol 1999, 49:45–50. This is the first study that describes the arthritogenic potential, in rats, of endogenous lipids, such as squalene and exogenous hydrocarbons.PubMedCrossRefGoogle Scholar
  4. 4.
    Simelyte E, Rimpilainen M, Rantakokko K, et al.: Tissue distri-bution and persistence of arthritogenic and non-arthritogenic Eubacterium cell walls. Clin Exp Rheumatol 1999, 17:281–288.PubMedGoogle Scholar
  5. 5.
    Yoshino S, Murata Y, Ohsawa M: Successful induction of adjuvant arthritis in mice by treatment with a monoclonal antibody against IL-4. J Immunol 1998, 161:6904–6908. Mice are generally resistant to classic adjuvant arthritis. This paper provides insights into mechanisms mediating resistance.PubMedGoogle Scholar
  6. 6.
    Remmers EF, Longman RE, Du Y, et al.: A genome scan local-izes five non-MHC loci controlling collagen-induced arthritis in rats. Nat Genet 1996, 14:82–85.PubMedCrossRefGoogle Scholar
  7. 7.
    Gulko PS, Kawahito Y, Remmers EF, et al.: Identification of a new non-major histocompatibility complex genetic locus on chromosome 2 that controls disease severity in collagen-induced arthritis in rats. Arthritis Rheum 1998, 41:2122–2131. To identify the non-MHC regulatory loci, a genome-wide search for regu-latory loci controlling CIA in response to native rat type II collagen is pre-sented in this paper. This study resulted in the identification of two new non-MHC QTL regulating collagen-induced arthritis severity.PubMedCrossRefGoogle Scholar
  8. 8.
    Vingsbo-Lundberg C, Nordquist N, Olofsson P, et al.: Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats. Nat Genet 1998, 20:401–404. The genetic basis for pristane-induced arthritis in rats has been described for the first time in this paper. The findings demonstrate that different phases of the chronic disease are associated with distinct sets of genes. This study resulted in the identification of QTL regulating PIA, several of which overlap with the QTL regulating other autoimmune diseases in rats, mice and humans.PubMedCrossRefGoogle Scholar
  9. 9.
    Wilder RL, Griffiths MM, Remmers EF, et al.: Localization in rats of genetic loci regulating susceptibility to experimental erosive arthritis and related autoimmune diseases. Transplantation Proc 1999, 31:1585–1588.CrossRefGoogle Scholar
  10. 10.
    Kawahito Y, Cannon GW, Gulko PS, et al.: Localization of quantitative trait loci regulating adjuvant-induced arthritis in rats: evidence for genetic factors common to multiple autoimmune diseases. J Immunol 1998, 161:4411–4419. This is the first genome-wide scan reported for Mtb-adjuvant-induced arthritis rat model that resulted in the detection of genetic factors respon-sible for adjuvant-induced arthritis severity in DA x F344, F2 rats.PubMedGoogle Scholar
  11. 11.
    Lorentzen JC, Glaser A, Jacobsson L, et al.: Identification of rat susceptibility loci for adjuvant-oil-induced arthritis. Proc Natl Acad Sci U S A 1998, 95:6383–6387. Conventional adjuvant models employ Mycobacterial species mixed with mineral oil adjuvant as the arthritogenic agent. The genetic control for this form of disease includes the combined effect of the mycobacter-ial component as well as the oil-component of the adjuvant. This study is particularly interesting for the reason that it deals with the arthritoge-nic potential of mineral oil alone (IFA) and mapping of the genetic loci conferring susceptibility to oil-induced arthritis in rats. Overlap of mapped loci with other experiment models was noted.PubMedCrossRefGoogle Scholar
  12. 12.
    Dracheva SV, Remmers EF, Gulko PG, et al.: Identification of a new quantitative trait locus on chromosome 7 controlling disease severity of collagen-induced arthritis in rats. Immuno-genetics 1999, In press.Google Scholar
  13. 13.
    McIndoe RA, Bohlman B, Chi E, et al.: Localization of non-Mhc collagen-induced arthritis susceptibility loci in DBA/1j mice. Proc Natl Acad Sci U S A 1999, 96:2210–2214. This study adds to evolving understanding of the location of non-MHC genes regulating CIA in micePubMedCrossRefGoogle Scholar
  14. 14.
    Jirholt J, Cook A, Emahazion T, et al.: Genetic linkage analysis of collagen-induced arthritis in the mouse. Eur J Immunol 1998, 28:3321–3328. This study describes the genetic mapping of regulatory loci control-ling arthritis in B10.RIII x RIIIS/J F2 mice that detected a QTL on chromosome 3, the homologous region of which in rats also harbors a regulatory locus for CIA (Cia10).PubMedCrossRefGoogle Scholar
  15. 15.
    Cremer MA, Ye XJ, Terato K, et al.: Immunity to type IX collage in rodents: a study of type IX collagen for autoimmune and arthritogenic activities. Clin Exp Immunol 1998, 112:375–382.PubMedCrossRefGoogle Scholar
  16. 16.
    Kerlund K, Erlandsson HH, Tracey KJ, et al.: Anti-inflammatory effects of a new tumor necrosis factor-alpha (TNF-alpha) inhibitor (CNI-1493) in collagen-induced arthritis (CIA) in rats. Clin Exp Immunol 1999, 115:32–41.PubMedCrossRefGoogle Scholar
  17. 17.
    Bendele A, McAbee T, Sennello G, et al.: Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data. Arthritis Rheum 1999, 42:498–506.PubMedCrossRefGoogle Scholar
  18. 18.
    Janusz MJ, Durham SL: Inhibition of cartilage degradation in rat collagen-induced arthritis but not adjuvant arthritis by the neutrophil elastase inhibitor MDL 101,146. Inflamm Res 1997, 46:503–508.PubMedCrossRefGoogle Scholar
  19. 19.
    Carlsen S. Hansson AS, Olsson H, et al.: Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats. Clin Exp Immunol 1998, 114:477–484.PubMedCrossRefGoogle Scholar
  20. 20.
    Dahlman I, Lorentzen JC, de Graaf KL, et al.: Quantitative trait loci disposing for both experimental arthritis and encephalo-myelitis in the DA rat; impact on severity of myelin oligoden-drocyte glycoprotein-induced experimental autoimmune encephalomyelitis and antibody isotype pattern. Eur J Immunol 1998, 28:2188–2196.PubMedCrossRefGoogle Scholar
  21. 21.
    Moudgil KD: Diversification of response to Hsp65 during the course of autoimmune arthritis is regulatory rather than pathogenic. Immunol Rev 1998, 164:175–184. The author reviews here that during the course of adjuvant arthritis (AA) in the LEW rat, there is ‘diversification’ of response to the bacterial 65-kD heat shock protein (Bhsp65) towards its carboxy-terminal determi-nants (BCTD). Strikingly, pretreatment of naive LEW rats with BCTD affords significant protection from AA. The studies also indicate that the diversification of response to BCTD in the LEW rat is probably triggered in vivo by the induction and enhanced processing of self (rat) Hsp65. Thus, the self Hsp65-directed T-cell responses appear to be involved in mediating natural remission from acute inflammatory arthritis induced by a foreign antigen, Mycobacterium tuberculosis.PubMedCrossRefGoogle Scholar
  22. 22.
    van Eden W, van der Zee R, Taams LS, et al.: Heat-shock protein T-cell epitopes trigger a spreading regulatory control in a diversified arthritogenic T-cell response. Immunol Rev 1998, 164:169–174.PubMedCrossRefGoogle Scholar
  23. 23.
    Barnes DA, Tse J, Kaufhold M, et al.: Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model. J Clin Invest 1998, 101:2910–2919.PubMedGoogle Scholar
  24. 24.
    Birner U, Issekutz TB, Issekutz AC: The role of selectins in VLA-4 and CD18-independent neutrophil migration to joints of rats with adjuvant arthritis. Eur J Immunol 1999, 29:1094–1100.PubMedCrossRefGoogle Scholar
  25. 25.
    Okazaki Y, Tsurukami H, Nishida S, et al.: Prednisolone prevents decreases in trabecular bone mass and strength by reducing bone resorption and bone formation defect in adjuvant-induced arthritic rats. Bone 1998, 23:353–360.PubMedCrossRefGoogle Scholar
  26. 26.
    Sun SH, Silver PB, Caspi RR, et al.: Identification of genomic regions controlling experimental autoimmune uveoretinitis in rats. Int Immunol 1999, 11:529–534.PubMedCrossRefGoogle Scholar
  27. 27.
    Vingsbo-Lundberg C, Saxne T, Olsson H, et al.: Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats. Arthritis Rheum 1998, 41:544–550.PubMedCrossRefGoogle Scholar
  28. 28.
    Song XY, Gu M, Jin WW, et al.: Plasmid DNA encoding trans-forming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. J Clin Invest 1998, 101:2615–2621.PubMedGoogle Scholar
  29. 29.
    Schimmer RC, Schrier DJ, Flory CM, et al.: Streptococcal cell wall-induced arthritis: requirements for IL-4, IL-10, IFN-gamma, and monocyte chemoattractant protein-1. J Immunol 1998, 160:1466–1471.PubMedGoogle Scholar
  30. 30.
    Kuiper S, Joosten LA, Bendele AM, et al.: Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis. Cytokine 1998, 10:690–702.PubMedCrossRefGoogle Scholar
  31. 31.
    Miagkov AV, Kovalenko DV, Brown CE, et al.: NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci U S A 1998, 95:13859–13864. The systemic effects of local suppression of NF-kB has been examined in this paper. The results establish a mechanism regulating apoptosis in the arthritic joint and indicate the feasibility of therapeutic approaches to RA based on the specific suppression of NF-kB.PubMedCrossRefGoogle Scholar
  32. 32.
    Anthony DD, Haqqi TM: Collagen-induced arthritis in mice: an animal model to study the pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 1999, 17:240–244.PubMedGoogle Scholar
  33. 33.
    Bradley DS, Nabozny GH, Cheng S, et al.: HLA-DQB1 polymor-phism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice: implications in human rheumatoid arthritis. J Clin Invest 1997, 100:2227–2234.PubMedCrossRefGoogle Scholar
  34. 34.
    Bradley DS, Das P, Griffiths MM, et al.: HLA-DQ6/8 double transgenic mice develop auricular chondritis following type II collagen immunization: a model for human relapsing polyarthritis. J Immunol 1998, 161:5046–5053.PubMedGoogle Scholar
  35. 35.
    Taneja V, Griffiths MM, Luthra H, et al.: Modulation of HLA-DQ-restricted collagen-induced arthritis by HLA-DRB1 polymorphism. Int Immunol 1998, 10:1449–1457.PubMedCrossRefGoogle Scholar
  36. 36.
    Taneja V, David CS: HLA transgenic mice as humanized mouse models of disease and immunity. J Clin Invest 1998, 101:921–926.PubMedGoogle Scholar
  37. 37.
    Rosloniec EF, Brand DD, Myers LK, et al.: Induction of auto-immune arthritis in HLA-DR4 (DRB1-0401) transgenic mice by immunization with human and bovine type II collagen. J Immunol 1998, 160:2573–2578.PubMedGoogle Scholar
  38. 38.
    Mori L, de Libero G: Genetic control of susceptibility to collagen-induced arthritis in T cell receptor beta-chain transgenic mice. Arthritis Rheum 1998, 41:256–262.PubMedCrossRefGoogle Scholar
  39. 39.
    Tada Y, Nagasawa K, Ho A, et al.: CD28-deficient mice are highly resistant to collagen-induced arthritis. J Immunol 1999, 162:203–208.PubMedGoogle Scholar
  40. 40.
    Kleinau S, Martinsson P, Gustavsson S, et al.: Importance of CD23 for collagen-induced arthritis: delayed onset and reduced severity in CD23-deficient mice. J Immunol 1999, 162:4266–4270.PubMedGoogle Scholar
  41. 41.
    Svensson L, Jirholt J, Holmdahl R, et al.: B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 1998, 111:521–526.PubMedCrossRefGoogle Scholar
  42. 42.
    Plows D, Kontogeorgos G, Kollias G: Mice lacking mature T and B lymphocytes develop arthritic lesions after immuni-zation with type II collagen. J Immunol 1999, 162:1018–1023.PubMedGoogle Scholar
  43. 43.
    Mageed RA, Adams G, Woodrow D, et al.: Prevention of collagen-induced arthritis by gene delivery of soluble p75 tumour necrosis factor receptor. Gene Ther 1998, 5:1584–1592.PubMedCrossRefGoogle Scholar
  44. 44.
    Whalen JD, Lechman EL, Carlos CA, et al.: Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresse development of collagen-induced arthritis in both injected and uninjected paws. J Immunol 1999, 162:3625–3632.PubMedGoogle Scholar
  45. 45.
    Joosten LA, Helsen MM, Saxne T, et al.: Synergistic protection against cartilage destruction by low dose prednisolone and interleukin-10 in established murine collagen arthritis. Inflamm Re 1999, 48:48–55.CrossRefGoogle Scholar
  46. 46.
    Szabo C, Scott GS, Virag L, et al.: Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists. Br J Pharmacol 1998, 125:379–340.PubMedCrossRefGoogle Scholar
  47. 47.
    Malfait AM, Malik AS, Marinova Mutafchieva L, et al.: The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action. J Immunol 1999, 162:6278–6283.PubMedGoogle Scholar
  48. 48.
    Kasama T, Yamazaki J, Hanaoka R, et al.: Biphasic regulation of the development of murine type II collagen-induced arthritis by interleukin-12: possible involvement of endogenous interleukin-10 and tumor necrosis factor alpha. Arthritis Rheum 1999, 42:100–109.PubMedCrossRefGoogle Scholar
  49. 49.
    Alonzi T, Fattori E, Lazzaro D, et al.: Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 1998, 187:461–468. In this study, results are discussed in the light of the present knowl-edge of cytokine networks in chronic inflammatory disorders and suggest that IL-6 receptor antagonists might be beneficial for the treatment of RA.PubMedCrossRefGoogle Scholar
  50. 50.
    Takagi N, Mihara M, Moriya Y, et al.: Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis. Arthritis Rheum 1998, 41:2117–2121. Conclusions drawn from this study demonstrate that IL-6 produced after CII immunization appears to play an essential role in the immu-nity to CII, and that anti-IL-6R antibody reduces the development of CIA by suppressing IL-6 signal transduction.PubMedCrossRefGoogle Scholar
  51. 51.
    Ruchatz H, Leung BP, Wei XQ, et al.: Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol 1998, 160:5654–5660.PubMedGoogle Scholar
  52. 52.
    Campbell IK, Rich MJ, Bischof RJ, et al.: Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J Immunol 1998, 161:3639–3644.PubMedGoogle Scholar
  53. 53.
    Ma Y, Thornton S, Boivin GP, et al.: Altered susceptibility to collagen-induced arthritis in transgenic mice with aberrant expression of interleukin-1 receptor antagonist. Arthritis Rheum 1998, 41:1798–1805.PubMedCrossRefGoogle Scholar
  54. 54.
    Kageyama Y, Koide Y, Yoshida A, et al.: Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-gamma receptor. J Immunol 1998, 161:1542–1548.PubMedGoogle Scholar
  55. 55.
    Matthys P, Vermeire K, Mitera T, et al.: Anti-IL-12 antibody pre-vents the development and progression of collagen-induced arthritis in IFN-gamma receptor-deficient mice. Eur J Immunol 1998, 28:2143–2151.PubMedCrossRefGoogle Scholar
  56. 56.
    Nakagawa TY, Brissette WH, Lira PD, et al.: Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 1999, 10:207–217.PubMedCrossRefGoogle Scholar
  57. 57.
    Haqqi TM, Anthony DD, Gupta S, et al.: Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci U S A 1999, 96:4524–4529.PubMedCrossRefGoogle Scholar
  58. 58.
    Tsuji F, Oki K, Fujisawa K, et al.: Involvement of leukotriene B4 in arthritis models. Life Sci 1999, 64:PL51-PL56.PubMedCrossRefGoogle Scholar
  59. 59.
    Thompson SJ, Francis JN, Siew LK, et al.: An immunodominant epitope from mycobacterial 65-kDa heat shock protein protects against pristane-induced arthritis. J Immunol 1998, 160:4628–4634.PubMedGoogle Scholar
  60. 60.
    Beech JT, Siew LK, Ghoraishian M, et al.: CD4+ Th2 cells specific for mycobacterial 65-kilodalton heat shock protein protect against pristane-induced arthritis. Immunol 1997, 159:3692–3697.Google Scholar
  61. 61.
    Wooley PH, Sud S, Whalen JD, et al.: Pristane-induced arthritis in mice. V. Susceptibility to pristane-induced arthritis is determined by the genetic regulation of the T cell repertoire. Arthritis Rheum 1998, 41:2022–2031.PubMedCrossRefGoogle Scholar
  62. 62.
    Mikecz K, Dennis K, Shi M, et al.: Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis. Arthritis Rheum 1999, 42:659–668.PubMedCrossRefGoogle Scholar
  63. 63.
    Glant TT, Cs-Szabo G, Nagase H, et al.: Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteo-arthritic human cartilage. Arthritis Rheum 1998, 41:1007–1018.PubMedCrossRefGoogle Scholar
  64. 64.
    Zhang Y, Guerassimov A, Leroux JY, et al.: Induction of arthritis in BALB/c mice by cartilage link protein: involvement of distinct regions recognized by T and B lymphocytes. Am J Pathol 1998, 153:1283–1291.PubMedGoogle Scholar
  65. 65.
    Korganow AS, Ji H, Mangialaio S, et al.: From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999, 10:451–461. In this paper, the authors have described the role of T and B cells in their recently described T cell receptor transgenic mouse model that spontaneously develops a disease with most of the clinical, histologi-cal, and immunological features of rheumatoid arthritis in humans. Disease development in K/BxN mice is initiated by systemic T cell self-reactivity; it requires T cells, as expected, but B cells, more surpris-ingly, are also needed. The role of B cells was shown to involve the secretion of arthritogenic immunoglobulins suggesting that a similar scenario may unfold in some other arthritis models and in human patients, beginning with pervasive T-cell autoreactivity and ending in immunoglobulin-provoked joint destruction.PubMedCrossRefGoogle Scholar
  66. 66.
    Iwakura Y, Itagaki K, Ishitsuka C, et al.: The development of autoimmune inflammatory arthropathy in mice transgenic for the human T cell leukemia virus type-1 env-pX region is not dependent on H-2 haplotypes and modified by the expression levels of Fas antigen. J Immunol 1998, 161:6592–6598.PubMedGoogle Scholar
  67. 67.
    Kotani M, Tagawa Y, Iwakura Y: Involvement of autoimmunity against type II collagen in the development of arthritis in mice transgenic for the human T cell leukemia virus type I tax gene. Eur J Immunol 1999, 29:54–64.PubMedCrossRefGoogle Scholar
  68. 68.
    Kontoyiannis D, Pasparakis M, Pizarro TT, et al.: Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999, 10:387–398. This is a very interesting study that addresses the impact of deleting TNF AU-rich elements (ARE) from the mouse genome on the regula-tion of TNF biosynthesis and the physiology of the host. Absence of the ARE affected the mechanisms responsible for TNF mRNA desta-bilization and translational repression in hemopoietic and stromal cells. Development of chronic inflammatory arthritis and Crohn’s disease-like inflammatory bowel disease in the mutant mice suggests that defective function of ARE may be etiopathogenic for the develop-ment of analogous human pathologies.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 1999

Authors and Affiliations

  • Bina Joe
    • 1
  • Marie M. Griffiths
    • 2
  • Elaine F. Remmers
    • 1
  • Ronald L. Wilder
    • 1
  1. 1.Inflammatory Joint Diseases Section, Arthritis and Rheumatism BranchNational Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of HealthBethesdaUSA
  2. 2.Research Service, Veterans Affairs Medical Center and Department of Medicine/RheumatologyUniversity of UtahSalt Lake CityUSA

Personalised recommendations